Roche Diabetes is pioneering innovative diabetes technologies and services since more than 40 years.
Being a global leader in integrated diabetes management, more than 5,000 employees in over 100 markets worldwide work every day to support people with diabetes and those at risk to achieve more time in their target range and experience true relief from the daily therapy routines.
Roche Diabetes collaborates with caregivers, healthcare providers and payers to optimally manage this complex condition and contribute to sustainable care structures. Under the brand Accu-Chek and in collaboration with partners, Roche Diabetes creates value by providing integrated solutions to monitor glucose levels, deliver insulin and track as well as contextualise relevant data points for a successful therapy. By establishing a leading open ecosystem, connecting devices, digital solutions, Roche Diabetes will enable optimal personalised diabetes management and thus improve therapy outcomes.
Since 2017 mySugr, with its world leading mobile diabetes management app and services, is part of Roche Diabetes.
For more information please visit www.accu-chek.com and www.mysugr.com.